NCT03427307View on ClinicalTrials.gov

Serum Level of Lipopolysaccharide-binding Protein (LBP) and Atherosclerosis in Hemodialysis Patients

CompletedOBSERVATIONAL
Enrollment

360

Participants

Timeline

Start Date

June 3, 2018

Primary Completion Date

December 31, 2018

Study Completion Date

January 31, 2021

Conditions
Systemic Inflammatory Response Syndrome
Trial Locations (1)

Unknown

Tungs' Taichung MetroHarbour Hospital, Taichung

All Listed Sponsors
lead

Tungs' Taichung Metroharbour Hospital

OTHER

NCT03427307 - Serum Level of Lipopolysaccharide-binding Protein (LBP) and Atherosclerosis in Hemodialysis Patients | Biotech Hunter | Biotech Hunter